Moens Héloise, Delcambre Louise N, De Greef Axel, Leboutte Marie-Emeline, Baeck Marie
Dermatology, Cliniques Universitaires Saint-Luc, Brussels, BEL.
Pediatrics, Cliniques Universitaires Saint-Luc, Brussels, BEL.
Cureus. 2024 Aug 6;16(8):e66303. doi: 10.7759/cureus.66303. eCollection 2024 Aug.
Bullous pemphigoid (BP) is an acquired auto-immune blistering disease, which is uncommon during childhood. Infantile BP usually has a good prognosis with rare recurrence and the suspected triggers are vaccines or viruses. We report the case of a three-month-old infant girl who presented with BP a week after a SARS-CoV-2 infection and three weeks after the first doses of polio, tetanus, diphtheria, pertussis, Haemophilus influenzae type-b, hepatitis, and pneumococcus vaccinations. Both triggers (infection and vaccination) could be implicated as a slight recurrence was observed after the second doses of vaccines. Rapid clinical resolution was obtained with topical corticosteroids.
大疱性类天疱疮(BP)是一种获得性自身免疫性水疱病,在儿童期并不常见。婴儿期BP通常预后良好,复发罕见,疑似诱因是疫苗或病毒。我们报告一例三个月大女婴的病例,该患儿在感染新型冠状病毒2周后以及接种首剂脊髓灰质炎、破伤风、白喉、百日咳、b型流感嗜血杆菌、肝炎和肺炎球菌疫苗3周后出现BP。两种诱因(感染和疫苗接种)都可能与之相关,因为在接种第二剂疫苗后观察到有轻微复发。局部使用皮质类固醇后临床症状迅速缓解。